M Laruelle
Overview
Explore the profile of M Laruelle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
4295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weinstein J, van de Giessen E, Rosengard R, Xu X, Ojeil N, Brucato G, et al.
Mol Psychiatry
. 2017 Nov;
PMID: 29155803
This corrects the article DOI: 10.1038/mp.2017.107.
2.
Weinstein J, van de Giessen E, Rosengard R, Xu X, Ojeil N, Brucato G, et al.
Mol Psychiatry
. 2017 May;
23(6):1506-1511.
PMID: 28507321
Recent genetic, molecular and post-mortem studies suggest impaired dopamine (DA)-D2 receptor (D2R) trafficking in patients with schizophrenia (SZ). Imaging and preclinical studies have shown agonist-induced D2R internalization can be imaged...
3.
Ashworth S, Berges A, Rabiner E, Wilson A, Comley R, Lai R, et al.
Br J Pharmacol
. 2014 Mar;
171(5):1241-9.
PMID: 24670146
Background And Purpose: This study aimed to investigate the relationship between the plasma concentration (PK) of the novel histamine H3 receptor antagonist, GSK239512, and the brain occupancy of H(3) receptors...
4.
Castner S, Murthy N, Ridler K, Herdon H, Roberts B, Weinzimmer D, et al.
Neuropsychopharmacology
. 2014 Feb;
39(12):2742-9.
PMID: 24487737
Several lines of evidence suggest that schizophrenia is associated with deficits in glutamatergic transmission at the N-methyl-d-aspartate (NMDA) receptors. Glycine is a NMDA receptor co-agonist, and extracellular levels of glycine...
5.
Laruelle M, Descamps O, Lesage V
Acta Clin Belg
. 2014 Jan;
68(4):298-302.
PMID: 24455801
Introduction: A D-dimer (DD) test improves the diagnosis of PE (PE) when combined with clinical scores. However, as DD levels increase physiologically with age, this testing has less specificity in...
6.
Ding Y, Naganawa M, Gallezot J, Nabulsi N, Lin S, Ropchan J, et al.
Neuroimage
. 2013 Aug;
86:164-71.
PMID: 23933039
Background: Atomoxetine (ATX), a drug for treatment of depression and ADHD, has a high affinity for the norepinephrine transporter (NET); however, our previous study showed it had a blocking effect...
7.
Murthy N, Mahncke H, Wexler B, Maruff P, Inamdar A, Zucchetto M, et al.
Schizophr Res
. 2012 Feb;
139(1-3):87-91.
PMID: 22342330
A recent single-site study (Fisher et al., 2009. Am J Psychiatry. 166 (7) 805-11) showed that repeated training with the Brain Fitness Program (BFP) improved performance on a battery of...
8.
Passchier J, Gentile G, Porter R, Herdon H, Salinas C, Jakobsen S, et al.
Synapse
. 2010 Mar;
64(7):542-9.
PMID: 20196141
The type-1 glycine transporter (GlyT1) is an important target for the development of new medications for schizophrenia. A specific and selective positron emission tomography (PET) GlyT1 ligand would facilitate drug...
9.
Bullich S, Cot A, Gallego J, Gunn R, Suarez M, Pavia J, et al.
Neuroimage
. 2010 Jan;
50(4):1511-8.
PMID: 20083205
Reported values of D(2) receptor occupancy (RO) achieved by antipsychotic drugs tend to be lower when measured with (123)I-IBZM SPECT than with (11)C-Raclopride PET. Image degrading factors such as attenuation,...
10.